Serum Insulin-like Growth Factor-1 to Albumin Ratio as a Biomarker for Sarcopenia Severity in End-Stage Renal Disease Patients on Hemodialysis
Clinical trial NCT07586956 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07586956
- Sponsor
- Sohag University
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-01
- Primary completion
- 2026-09-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.